Orexigen Therapeutics is engaged in the development and commercialization of pharmaceutical products for the treatment of obesity.
Business Model:
Revenue: $75.3M
Employees: 51-200
Orexigen Therapeutics, Inc. was acquired by
Nalpropion Pharmaceuticals.
The acquisition happend on 2018-04-24.
Details of the transaction were not public
Address: 3344 N Torrey Pines Court
City: La Jolla
State: CA
Zip: 92037
Country: US
Orexigen Therapeutics is engaged in the development and commercialization of pharmaceutical products for the treatment of obesity.
Contact Phone:
+18588758600
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/26/2007
Ticker Symbol:
OREX
IPO Price:
$12/share
Amount Raised:
$84M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|